Fig. 1
From: Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
Percentage of BRCA1/2 positivity among different patients’ risk groups, N = 95*. Patients with BRCA1/2 deleterious or suspected deleterious mutations were considered BRCA1/2 positive. * Five patients (patients 061, 063, 020, 070 and 071) were relatives to the index case tested in their families, therefore they were excluded from this analysis, see footnote to Table 2. TN: Triple Negative breast cancer